Feedback Can Influence New Product Development and Innovation
MOUNTAIN VIEW, Calif., April 22 /PRNewswire/ -- The latest end-user study from Frost & Sullivan's Pharmaceuticals & Biotechnology group assesses a variety of critical dynamics of drug delivery approaches and technologies in cancer treatment. Physicians, nurses and patients provided insight on factors such as perception, usage, reconstitution, home vs. office administration parameters, and barriers of leading drug delivery types, providing insight and feedback to cancer treatment developers.
Selected findings from the survey include the following:
Through more than 240 detailed interviews with medical oncologists, infusion nurses and cancer patients (breast, colorectal, lung, prostate) in the U.S., research analysts identified key insights into drug treatment, utilization, and potential future approaches to drug delivery in oncology.
From the Analyst
"Understanding the views and desires of end users regarding cancer drug delivery is an important asset to pharmaceutical and biotechnology companies," notes Frost & Sullivan Pharmaceuticals & Biotechnology Industry Manager Daniel Ruppar.
"As companies seek new opportunities in cancer treatment, an understanding of users' views of drug delivery factors from several sides could influence and generate innovative portfolio and development decisions," explains Ruppar. "By understanding the needs, preferences, and other points of feedback of the delivery of cancer drugs from oncologists, infusion nurses and patients, developers can glean insight from viewpoints across the cancer treatment pathway."
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.
Contact: Johanna Haynes Frost & Sullivan 210-247-3870 firstname.lastname@example.org
|SOURCE Frost & Sullivan|
Copyright©2009 PR Newswire.
All rights reserved